p130Cas Is Required for Mammary Tumor Growth and Transforming Growth Factor-β-mediated Metastasis through Regulation of Smad2/3 Activity
Authors:
- Michael K. WendtMWMichael K. Wendt
- Jason A. SmithJSJason A. Smith
- William P. SchiemannWSWilliam P. Schiemann
Open Access
- 1 December 2009
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 284 (49) , 34145-34156
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Therapeutic targeting of the focal adhesion complex prevents oncogenic TGF-β signaling and metastasisBreast Cancer Research, 2009
- A Novel Association between p130Cas and Resistance to the Chemotherapeutic Drug Adriamycin in Human Breast Cancer CellsCancer Research, 2008
- TRAF6 Mediates Smad-Independent Activation of JNK and p38 by TGF-βMolecular Cell, 2008
- Cox-2 inactivates Smad signaling and enhances EMT stimulated by TGF- through a PGE2-dependent mechanismsCarcinogenesis, 2008
- The Integrin-coupled Signaling Adaptor p130Cas Suppresses Smad3 Function in Transforming Growth Factor-β SignalingMolecular Biology of the Cell, 2008
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem CellsCell, 2008
- Grb2 binding to Tyr284 in TβR-II is essential for mammary tumor growth and metastasis stimulated by TGF-βCarcinogenesis, 2008
- The morphologies of breast cancer cell lines in three‐dimensional assays correlate with their profiles of gene expressionMolecular Oncology, 2007
- Tissue Geometry Determines Sites of Mammary Branching Morphogenesis in Organotypic CulturesScience, 2006
- Transforming growth factor β-induced phosphorylation of Smad3 is required for growth inhibition and transcriptional induction in epithelial cellsProceedings of the National Academy of Sciences, 1997